跳至主要内容
临床试验/JPRN-jRCT1041200094
JPRN-jRCT1041200094招募中未知

Efficacy of administering remimazolam at anesthetic management for Asleep-Awake-Asleep method of awake craniotomy;Randomized control study

ishiwaki Kimitoshi0 个研究点目标入组 58 人开始时间: 2021年1月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 15age old 至 <= 70age old(—)
性别
All

入选标准

  • Patients who undergo elective awake craniotomy

排除标准

  • 1)Patients who do not agree.
  • 2)have a liver disfunction(Child-pugh classification B or higher).
  • 3)have an allergy for the ropivacaine and other anesthetics drugs.
  • 4)have an obvious hemostatic dysfunction(Platelet count of 80000 or less,PT-INR of 1.5 or more,APTT of 40 seconds or more).
  • 5)have a severe respiratory disorder(%VC<60%,orFEV1%<50%).
  • 6)have a primary closed angle glaucoma
  • 7)have a heart failure (ejection fraction of 45% or less on echocardiography, presence of severe valvular disease, and past history of coronary artery disease).
  • 8)patient who can not be in candidate at this study decided by the doctor

研究者

发起方
ishiwaki Kimitoshi

相似试验